Answers are grounded in this paper and cite their sources.
Case report reveals pituitary abnormalities in refractory cluster headaches, suggesting necessary hormone testing.
Pituitary hormone testing is recommended in refractory cluster headache (CH), but supporting evidence is limited. We present a patient with cluster-like headaches and a negative brain magnetic resonance imaging (MRI) 1 year after headache onset. He failed multiple medication trials. Three years after headache onset, additional workup showed abnormal pituitary labs including hyperprolactinemia and a brain MRI with a 15 × 15 × 14 mm 3 enhancing pituitary lesion. With cabergoline 0.25 mg twice weekly, the patient has been headache-free for over 2 years. This case supports the recommendations for pituitary testing in refractory CH, even if imaging is initially negative for a pituitary tumor.
No takes yet. Share an insight, caveat, or question.
Ihezie et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: